Literature DB >> 14653850

Unchanged striatal dopamine transporter availability in narcolepsy: a PET study with [11C]-CFT.

J O Rinne1, C Hublin, K Någren, H Helenius, M Partinen.   

Abstract

OBJECTIVE: To investigate dopamine reuptake sites (dopamine transporter) in the caudate nucleus and putamen in narcolepsy. PATIENTS AND METHODS: Ten patients with narcolepsy and 15 controls were studied with positron emission tomography. A cocaine analogue [11C]-CFT was used as a radioligand.
RESULTS: The uptake of[11C]-CFT was within normal limits (89% of age-adjusted control mean in the caudate nucleus and 91% in the putamen) in patients with narcolepsy.
CONCLUSIONS: No evidence of altered striataldopamine transporter availability was found in narcolepsy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14653850     DOI: 10.1034/j.1600-0404.2003.00175.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  4 in total

1.  Striatal dopamine D1-like receptor binding is unchanged in primary focal dystonia.

Authors:  Morvarid Karimi; Stephen M Moerlein; Tom O Videen; Yi Su; Hubert P Flores; Joel S Perlmutter
Journal:  Mov Disord       Date:  2013-10-21       Impact factor: 10.338

Review 2.  Neuroimaging findings in narcolepsy with cataplexy.

Authors:  Thien Thanh Dang-Vu
Journal:  Curr Neurol Neurosci Rep       Date:  2013-05       Impact factor: 5.081

Review 3.  Neuroimaging insights into the pathophysiology of sleep disorders.

Authors:  Martin Desseilles; Thanh Dang-Vu; Manuel Schabus; Virginie Sterpenich; Pierre Maquet; Sophie Schwartz
Journal:  Sleep       Date:  2008-06       Impact factor: 5.849

4.  Complex movement disorders at disease onset in childhood narcolepsy with cataplexy.

Authors:  Giuseppe Plazzi; Fabio Pizza; Vincenzo Palaia; Christian Franceschini; Francesca Poli; Keivan K Moghadam; Pietro Cortelli; Lino Nobili; Oliviero Bruni; Yves Dauvilliers; Ling Lin; Mark J Edwards; Emmanuel Mignot; Kailash P Bhatia
Journal:  Brain       Date:  2011-09-19       Impact factor: 13.501

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.